Human Resources
Novo Nordisk leader unpacks the trends set to redefine work: International HR Day
On International HR Day (20 May), Eleanor Clifford, Senior Director of People and Organisation at Novo Nordisk ANZ, offers a […]
MoreHuman Resources
Decoding Novartis’ blueprint for AI-powered workforce and a reimagined workplace: International HR Day
As International HR Day (20 May) spotlights the theme HumanifyAI – Leading Change in a Dynamic World, Saada McNamee, Country […]
MoreHuman Resources
How Australia’s employee engagement measures up
Australia is facing a decline in employee engagement, with just 16% of workers feeling fully engaged in their roles – […]
MoreHuman Resources
Reality check: Australians divided on gender equality while evidence paints a different picture
Australians are split. Half think women in Australia today are treated fairly and have access to equal opportunities, half say […]
MoreHuman Resources
Return-to-office mandates: A backward step or necessary reset?
The debate over return-to-office mandates is reigniting tensions between employers and employees, as both sides grapple with defining the future […]
MoreHuman Resources
New Bill forces companies to set gender equality targets
Australia’s latest move to tackle gender inequality in the workplace is set to send ripples across nearly 2,000 employers with […]
MoreHuman Resources
Family-friendly workplaces expand despite unpopular return-to-office policies
Having driven significant policy change in Australia and supported over 650 organisations in improving their family-friendly work practices, the movement […]
MoreHuman Resources
Best Workplaces for Women recognised while Peter Dutton suggests they settle for less
AbbVie, BeiGene, Boston Scientific, Novo Nordisk, MSD, and Sandoz have been named among the Best Workplaces for Women in 2025 […]
MoreHuman Resources
How does the new gender pay gap data measure up across the pharma, medtech and diagnostics sectors?
The latest release of employer gender pay gap data provides deeper insights into workplace gender equality, affecting more than 5.3 […]
MoreHuman Resources
Navigating the evolving workforce and workplaces: Experts talk trends and strategies
Amidst ongoing global and domestic political shifts, economic uncertainties, and persistent pricing pressures, the healthcare industry is navigating a cautious […]
MoreRecent Posts in Pharma, MedTech & Biotech
Philips remote monitoring cuts hospital costs and ICU time by 69%
August 1, 2025
in News - MedTech & Diagnostics
VB Spine breaks ground in ANZ, Takes over Stryker’s spinal implants business
August 1, 2025
in News - MedTech & Diagnostics
New therapy PBS listed in advanced Parkinson’s disease
August 1, 2025
in News - Pharmaceuticals
PBS adds first ustekinumab and omalizumab biosimilars in inflammatory and allergic conditions
August 1, 2025
in News - Pharmaceuticals
November PBAC agenda unveiled amid tensions over tariff risks
July 31, 2025
in News - Pharmaceuticals
Promises, pitfalls and pressure points: Stakeholders weigh in on government’s AI healthcare report
July 31, 2025
in News - MedTech & Diagnostics
MSAC to consider funding for first TGA-approved TTVR device
July 31, 2025
in News - MedTech & Diagnostics
The triple squeeze on leaders and a messy middle: New future of work report
July 30, 2025
in Leadership & Management
Follow Us
Partner with us
News - MedTech & Diagnostics
Philips remote monitoring cuts hospital costs and ICU time by 69%
An innovative remote patient monitoring model has significantly improved post-operative care for patients, cutting ICU hours by 69% and saving […]
MoreNews - MedTech & Diagnostics
VB Spine breaks ground in ANZ, Takes over Stryker’s spinal implants business
VB Spine has officially taken the reins of Stryker’s spinal implants business in Australia and New Zealand. The transition builds […]
MoreNews - Pharmaceuticals
New therapy PBS listed in advanced Parkinson’s disease
A new therapeutic option for advanced Parkinson’s disease, Vyalev (foslevodopa with foscarbidopa), is now listed on the Pharmaceutical Benefits Scheme […]
MoreNews - Pharmaceuticals
PBS adds first ustekinumab and omalizumab biosimilars in inflammatory and allergic conditions
From 1 August 2025, two new biosimilars – SteQeyma (ustekinumab) and Omlyclo (omalizumab) – have been listed on the Pharmaceutical […]
More